CoChat

Inhibition of Allergen-Induced Airway Remodeling in Smad 3-Deficient Mice

Le, Annie V, Cho, Jae Youn, Miller, Marina, McElwain, Shauna, Golgotiu, Kirsti, Broide, David H · 2007 · The Journal of Immunology
Cited by 124

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Intracellular signaling pathways that converge on Smad 3 are used by both TGF-β and activin A, key cytokines implicated in the process of fibrogenesis. To determine the role of Smad 3 in allergen-induced airway remodeling, Smad 3-deficient and wild-type (WT) mice were sensitized to OVA and challenged by repetitive administration of OVA for 1 mo. Increased levels of activin A and increased numbers of peribronchial TGF-β1+ cells were detected in WT and Smad 3-deficient mice following repetitive OVA challenge. Smad 3-deficient mice challenged with OVA had significantly less peribronchial fibrosis (total lung collagen content and trichrome staining), reduced thickness of the peribronchial smooth muscle layer, and reduced epithelial mucus production compared with WT mice. As TGF-β and Smad 3 signaling are hypothesized to mediate differentiation of fibroblasts to myofibroblasts in vivo, we determined the number of peribronchial myofibroblasts (Col-1+ and α-smooth muscle actin+) as assessed by double-label immunofluorescence microscopy. Although the number of peribronchial myofibroblasts increased significantly in WT mice following OVA challenge, there was a significant reduction in the number of peribronchial myofibroblasts in OVA-challenged Smad 3-deficient mice. There was no difference in levels of eosinophilic airway inflammation or airway responsiveness in Smad 3-deficient compared with WT mice. These results suggest that Smad 3 signaling is required for allergen-induced airway remodeling, as well as allergen-induced accumulation of myofibroblasts in the airway. However, Smad 3 signaling does not contribute significantly to airway responsiveness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.178.11.7310

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • TGF-β signaling and the fibrotic response

    Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319 · cited 1×

    “The profibrotic cytokine, TGF- , and its close homolog, activin A, both of which activate cellular responses through the Smad signaling pathway, are hypothesized to play an essential role in promoting the structural changes of tissue remodeling (2).”
    Background
  • Smad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression

    Hu, B., Wu, Z., & Phan, S. H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0063oc · Cited by 325 · cited 1×

    “EMSAs and DNA high-affinity precipitation studies have furthermore determined that Smad 3 binding to promoters containing CAGA motifs or Smad 3-binding elements is required for -SMA expression of fibroblasts (31, 32), providing a mechanistic pathway by which TGF- , through the direct actions of Smad 3, may induce myof…”
    Background

Show all 2 references

Cited by

Metadata

Authors
Le, A. V., Cho, J. Y., Miller, M., McElwain, S., Golgotiu, K., & Broide, D. H.
Venue
The Journal of Immunology
Published
2007-06-01
Volume
178
Issue
11
Pages
7310-7316
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1632787824
Cited by
124
References
2
FWCI
7.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.